Back to search

Prognostic Factors in Breast Cancer

Data up to Jan 2025

Published1990
Citations24
References82

Total Citations Per Year

Abstract

References (82)

Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu Oncogene

1987 • 11,429 citations

Studies of the HER-2/ neu Proto-Oncogene in Human Breast and Ovarian Cancer

1989 • 6,734 citations

Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer

1988 • 921 citations

EPIDERMAL-GROWTH-FACTOR RECEPTOR STATUS AS PREDICTOR OF EARLY RECURRENCE OF AND DEATH FROM BREAST CANCER

1987 • 881 citations

Neu-Protein Overexpression in Breast Cancer

1988 • 860 citations

Effects of adjuvant tamoxifen and of cytotoxic therapy on mortality in early breast cancer. An overview of 61 randomized trials among 28,896 women

1988 • 631 citations

Expression of c-erbB-2 oncoprotein: a prognostic indicator in human breast cancer.

1989 • 592 citations

HER-2/neu oncogene protein and prognosis in breast cancer.

1989 • 579 citations

Prediction of Relapse or Survival in Patients with Node-Negative Breast Cancer by DNA Flow Cytometry

1989 • 571 citations

Prognostic factors of breast recurrence in the conservative management of early breast cancer: A 25-year follow-up

1989 • 514 citations

Cathepsin D and Prognosis in Breast Cancer

1990 • 473 citations

Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant Breast and Bowel Project Protocol B-06.

1988 • 415 citations

Survival from first recurrence: relative importance of prognostic factors in 1,015 breast cancer patients.

1987 • 380 citations

CATHEPSIN D: AN INDEPENDENT PROGNOSTIC FACTOR FOR METASTASIS OF BREAST CANCER

1989 • 327 citations

Correlation between long-term survival in breast cancer patients and amplification of two putative oncogene-coamplification units: hst-1/int-2 and c-erbB-2/ear-1.

1989 • 321 citations

POSSIBLE ROLE FOR VITAMIN D IN CONTROLLING BREAST CANCER CELL PROLIFERATION

1989 • 284 citations

Ki67 immunostaining in primary breast cancer: pathological and clinical associations

1989 • 267 citations

Somatostatin receptors in human endocrine tumors.

1987 • 253 citations

Important Advances in Oncology 1988

1988 • 253 citations

Association between high concentrations of Mr 52,000 cathepsin D and poor prognosis in primary human breast cancer.

1989 • 250 citations

ALLELE LOSS ON SHORT ARM OF CHROMOSOME 17 IN BREAST CANCERS

1988 • 236 citations

EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTORS ASSOCIATED WITH LACK OF RESPONSE TO ENDOCRINE THERAPY IN RECURRENT BREAST CANCER

1989 • 224 citations

Prognostic value of receptors for insulin-like growth factor 1, somatostatin, and epidermal growth factor in human breast cancer.

1989 • 217 citations

Receptors for epidermal growth factor and insulin-like growth factor I and their relation to steroid receptors in human breast cancer.

1988 • 208 citations

Characteristics and distribution of receptors for [d‐trp6]‐ luteinizing hormone‐releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer

1989 • 203 citations

Direct inhibitory effects of somatostatin (analogues) on the growth of human breast cancer cells.

1987 • 191 citations

Prediction of relapse and survival in breast cancer patients by pS2 protein status.

1990 • 179 citations

Insulin-like growth factor 1 receptors in human breast cancer and their relation to estradiol and progesterone receptors.

1988 • 173 citations

Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods.

1989 • 168 citations

Androgen receptors in breast cancer

1984 • 167 citations

Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis

1986 • 155 citations

Proto-oncogene amplification and human breast tumor phenotype

1990 • 154 citations

HER-2 amplification, steroid receptors and epidermal growth factor receptor in primary breast cancer.

1989 • 150 citations

Prognostic significance of the estrogen-regulated protein, cathepsin D, in breast cancer. An immunohistochemical study

1990 • 150 citations

Growth rate, kinetics of tumor cell proliferation and long‐term outcome in human breast cancer

1989 • 141 citations

Haptoglobin-Related Protein (Hpr) Epitopes in Breast Cancer as a Predictor of Recurrence of the Disease

1989 • 129 citations

Prognostic value of estrogen and progesterone receptors measured by enzyme immunoassays in human breast tumor cytosols.

1989 • 120 citations

Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer

1989 • 119 citations

Predictors of Recurrence and Survival of Patients with Breast Cancer

1987 • 119 citations

Control of human breast cancer by estrogen, growth factors, and oncogenes

1988 • 110 citations

Tyrosine kinase activity in breast cancer, benign breast disease, and normal breast tissue.

1989 • 105 citations

Racial differences in survival of women with breast cancer

1986 • 105 citations

Intratumoral aromatase as a prognostic factor in human breast carcinoma.

1989 • 105 citations

The prognostic value and relationships of patient characteristics, estrogen and progestin receptors, and site of relapse in primary breast cancer

1988 • 103 citations

Elevated Growth Hormone Levels in Sera from Breast Cancer Patients

1985 • 96 citations

Cell kinetics as a prognostic indicator in node-negative breast cancer

1989 • 93 citations

Hyperprolactinemia is an indicator of progressive disease and poor prognosis in advanced breast cancer

1984 • 84 citations

Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis.

1988 • 82 citations

The multivariate prognostic index and nuclear DNA content are independent prognostic factors in primary breast cancer patients

1989 • 77 citations

Prognostic value of epidermal growth factor receptor in node-positive breast cancer

1989 • 73 citations

Multiparametric evaluation (SAMBA) of growth fraction (monoclonal Ki67) in breast carcinoma tissue sections.

1988 • 72 citations

Prognostic significance of the receptor for epidermal growth factor in human mammary carcinomas.

1987 • 63 citations

The relationship between somatostatin, epidermal growth factor, and steroid hormone receptors in breast cancer

1989 • 59 citations

Carcinoembryonic antigen in breast cancer. Clinical review

1986 • 57 citations

Age as a prognostic factor in breast cancer

1985 • 54 citations

Correlative study on neuro‐endocrine differentiation and presence of somatostatin receptors in breast carcinomas

1989 • 54 citations

Factors affecting relapse in node-negative breast cancer. A multivariate analysis including the labeling index

1989 • 51 citations

Genetic alterations in primary breast cancer

1989 • 49 citations

Cell kinetics in selection and stratification of patients for adjuvant therapy of breast carcinoma.

1986 • 42 citations

Prognostic significance of prolactin receptors in human breast cancer.

1987 • 41 citations

CA15-3: Its relationship to clinical stage and progression to metastatic disease in breast cancer

1989 • 41 citations

Progesterone receptor activity and relapse-free survival in patients with primary breast cancer: The role of adjuvant chemotherapy

1987 • 39 citations

Presence and characterization of insulin-like growth factor 1 receptors in human benign breast disease

1988 • 39 citations

Growth inhibition of MXT mammary carcinoma by enhancing programmed cell death (apoptosis) with analogs of LH-RH and somatostatin

1989 • 38 citations

The relationship between histological grade, oestrogen receptor status, events and survival at 8 years in the NATO ('Nolvadex') trial

1988 • 38 citations

Prognostic significance of micrometastases in bone marrow in patients with primary breast cancer.

1986 • 35 citations

Prognostic value of estrogen and prolactin receptor analysis in human breast cancer.

1985 • 30 citations

Epidermal growth factor receptors in human breast cancer

1988 • 27 citations

Breast Cancer. Treatment and Prognosis

1987 • 21 citations

Biochemical markers as prognostic indices in breast cancer

1990 • 21 citations

Relationship of tumor prostaglandin levels to early recurrence in women with primary breast cancer: clinical update.

1986 • 20 citations

Heterogeneity of genetic alterations in primary human breast tumors

1988 • 17 citations

Lack of relationship between the levels of prolactin receptors and steroid receptors in women with breast cancer.

1988 • 14 citations

Long-Term Survival and Prognostic Factors for 2170 Breast Cancer Patients Treated at Two Cancer Centers: (Milan and Houston)

1989 • 13 citations

The expression of milk fat globule antigens within human mammary tumours: Relationship to steroid hormone receptors and response to endocrine treatment

1989 • 13 citations

Plasminogen activator expression and steroid hormone receptors in female breast cancer: A multifactorial study

1988 • 13 citations

The pathologist and the clinical oncologist: a new effective partnership in assessing tumor prognosis

1989 • 11 citations

Adjuvant treatment of node-negative breast cancer.

1989 • 6 citations

Correlation of Fcγ receptors on peripheral blood mononuclear cells and survival in patients with metastatic breast cancer

1986 • 6 citations

Epidermal growth factor receptor: A marker of early relapse in breast cancer: Interactions with NEU

1990 • 4 citations

Predictors of hormone response for patients with ER-unknown breast tumours

1989 • 3 citations

Deleted Work

1955 • 0 citations

Cited By (0)

Loading...
Prognostic Factors in Breast Cancer (1990) – Springer eBooks | Metascience Observatory Explorer